Toi M - Search Results

1

Predictive value of CD24 and CD44 for neoadjuvant chemotherapy response and prognosis in primary breast cancer patients.

Horiguchi K, Toi M, Horiguchi S, Sugimoto M, Naito Y, Hayashi Y, Ueno T, Ohno S, Funata N, Kuroi K, Tomita M, Eishi Y. Horiguchi K, et al. Among authors: toi m. J Med Dent Sci. 2010 Jun;57(2):165-75. J Med Dent Sci. 2010. PMID: 21073135

2

Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Am J Surg. 1992 Oct;164(4):323-6. doi: 10.1016/s0002-9610(05)80897-9. Am J Surg. 1992. PMID: 1357997

3

[Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients].

Osaki A, Toi M, Yamada H, Kawami H, Kuroi K, Toge T. Osaki A, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1991 Jun;18(7):1181-5. Gan To Kagaku Ryoho. 1991. PMID: 1675844 Japanese.

4

Primary squamous cell carcinoma of the breast after cured Hodgkin's disease.

Kuroi K, Osaki A, Yamada H, Toi M, Toge T, Takimoto Y, Kuramoto A, Arihiro K, Inai K. Kuroi K, et al. Among authors: toi m. Surg Today. 1993;23(1):81-4. doi: 10.1007/BF00309006. Surg Today. 1993. PMID: 8461611

5

[New molecular target of cancer therapy--angiogenesis regulator VEGF].

Toi M, Ueno T, Tominaga T. Toi M, et al. Gan To Kagaku Ryoho. 1997 Dec;24(15):2202-6. Gan To Kagaku Ryoho. 1997. PMID: 9422062 Review. Japanese.

6

Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer.

Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, Iwanari H, Tominaga T. Toi M, et al. Clin Cancer Res. 1998 Mar;4(3):659-64. Clin Cancer Res. 1998. PMID: 9533534

7

Significance of thymidine phosphorylase as a marker of protumor monocytes in breast cancer.

Toi M, Ueno T, Matsumoto H, Saji H, Funata N, Koike M, Tominaga T. Toi M, et al. Clin Cancer Res. 1999 May;5(5):1131-7. Clin Cancer Res. 1999. PMID: 10353748

8

Significance of membrane type 1 matrix metalloproteinase expression in breast cancer.

Ishigaki S, Toi M, Ueno T, Matsumoto H, Muta M, Koike M, Seiki M. Ishigaki S, et al. Among authors: toi m. Jpn J Cancer Res. 1999 May;90(5):516-22. doi: 10.1111/j.1349-7006.1999.tb00778.x. Jpn J Cancer Res. 1999. PMID: 10391091 Free PMC article. Clinical Trial.

9

[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline].

Nagai S, Toi M, Kuroi K, Hayashi K, Tominaga T. Nagai S, et al. Among authors: toi m. Gan To Kagaku Ryoho. 1999 Nov;26(13):2037-42. Gan To Kagaku Ryoho. 1999. PMID: 10584568 Clinical Trial. Japanese.

10

Circulating soluble Fas concentration in breast cancer patients.

Ueno T, Toi M, Tominaga T. Ueno T, et al. Among authors: toi m. Clin Cancer Res. 1999 Nov;5(11):3529-33. Clin Cancer Res. 1999. PMID: 10589768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

787 results

Search Page

Filters